Foghorn Therapeutics Investors

24 investors on Angel Roster list Foghorn Therapeutics in their portfolio. Most are venture capital firms and entrepreneurship programs, the most common stage is Series A and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Foghorn Therapeutics can appear together.

Investors listed
24
With verified email
54%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Foghorn Therapeutics investors

The most complete profiles first. Showing 24 of 24.

  • Alex GoldsmithVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Avak KahvejianVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Ewen CameronVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Molly GibsonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Nick PlugisVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Sabrina YangVerified

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Sebastian TrousilVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Stephen BerensonVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Torben Straight NissenVerified

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Douglas ColeVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Ignacio MartinezVerified

    Venture Capital, Entrepreneurship Program · United States

    Health CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 52 more

    Verified email available

  • Jim GilbertVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Verified email available

  • Eytan Weinstein

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Geoffrey von Maltzahn

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Harry Wilcox

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 51 more

    Contact details available

  • Jacob Rubens

    Venture Capital, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Nathan Stebbins

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Yiqun Bai, Ph.D.

    Venture Capital, Entrepreneurship Program, Investor · United States

    Series AHealth CareWomen FoundedEnterprise SoftwareEnergy

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Doug ColeVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedBiotechnologyPharmaceuticals

    Portfolio: Sigilon Therapeutics, Syros Pharmaceuticals, Foghorn Therapeutics, Denali Therapeutics and 1 more

    Verified email available

  • John Casey

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

  • Noubar Afeyan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods and 50 more

    Contact details available

Frequently asked questions

How many Foghorn Therapeutics investors are on Angel Roster?

Angel Roster lists 24 Foghorn Therapeutics investors. 13 of them (54%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Entrepreneurship Programs (9) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Foghorn Therapeutics investors invest in?

Among those that list a stage, the most common are Series A (14), Seed (2) and Series B (1).

Where are Foghorn Therapeutics investors based?

Most are based in the United States (24).

Which companies have Foghorn Therapeutics investors backed?

The most-backed portfolio companies among them are Syros Pharmaceuticals (24), Codiak Biosciences (23), Editas Medicine (23), Repertoire Immune Medicines (21) and Denali Therapeutics (21).

How do I contact Foghorn Therapeutics investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.